United Kingdom· GB-APID-35735711000001102
Fotivda 890microgram capsules
A tivozanib product containing tivozanib, registered in United Kingdom by Recordati UK Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tivozanib is registered in 10 of 19 countries.
Countries holding a registration under ATC L01EK03 (tivozanib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Tivozanib · ATC L01EK03
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tivozanib
- Manufacturer
- Recordati UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EK03
- ATC class
- Tivozanib
- Defined daily dose
- 1 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5060146291712
- gtin5060146293075
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
7 interactions on record for tivozanib.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tivozanib · interactions on record
7 records
- 3 severe
- 4 moderate
Most severe, free to view
- PhenobarbitalN03AA02severe
- PhenobarbitalN05CA24severe
- Hyperici herbaN06AX25severe
- RiociguatC02KX05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tivozanib in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFOTIVDAAVEO Pharmaceuticals, Inc.
- CzechiaFOTIVDARecordati Netherlands B.V., Schiphol-Rijk
- SpainFOTIVDA 890 MICROGRAMOS CAPSULAS DURASRecordati Netherlands B.V.
- FinlandFotivdaRecordati Netherlands B.V.
- IrelandFotivda 890 microgram hard capsulesEUSA Pharma (Netherlands) B.V.
- BelgiumFotivda 890 µgRecordati Netherlands
- NorwayFotivdaRecordati Netherlands B.V.
- PolandFotivdaEUSA Pharma (Netherlands) B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fotivda
- Liechtenstein · Fotivda
- Norway · Fotivda
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/53049ea9-137e-4deb-ba1d-5fc33630590b GET /v1/drugs/53049ea9-137e-4deb-ba1d-5fc33630590b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "35735711000001102",
"desc": "Fotivda 890microgram capsules (Recordati UK Ltd)",
"form": "Oral capsule",
"vpid": "35750511000001103",
"source": "dmd",
"vtm_id": "777789005",
"strength": "890 microgram",
"substance": "Tivozanib",
"ingredient": "Tivozanib hydrochloride monohydrate",
"supplier_code": "13210911000001103"
}See everything about tivozanib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.